Sabharwal A K, Padmanabhan K, Tulinsky A, Mathur A, Gorka J, Bajaj S P
Department of Medicine, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.
J Biol Chem. 1997 Aug 29;272(35):22037-45. doi: 10.1074/jbc.272.35.22037.
Human factor X is a two-chain, 58-kDa, vitamin K-dependent blood coagulation zymogen. The light chain of factor X consists of an NH2-terminal gamma-carboxyglutamic acid (Gla) domain, followed by a few helical hydrophobic residues and the two epidermal growth factor-like domains, whereas the heavy chain contains the serine protease domain. In this study, native factor X was found to contain three classes of Ca2+-binding sites: two high affinity (Kd 100 +/- 30 microM), four intermediate affinity (Kd 450 +/- 70 microM), and five to six low affinity (Kd 2 +/- 0.2 mM). Decarboxylated factor X in which the Gla residues were converted to Glu retained the two high affinity sites (Kd 140 +/- 20 microM). In contrast, factor X lacking the Gla domain as well as a part of the helical hydrophobic residues (des-44-X) retained only one high affinity Ca2+-binding site (Kd 130 +/- 20 microM). Moreover, a synthetic peptide composed of residues 238-277 (58-97 in chymotrypsinogen numbering) from the protease domain of factor X bound one Ca2+ with high affinity (Kd 150 +/- 20 microM). From competitive inhibition assays for binding of active site-blocked factor Xa to factor Va in the prothrombinase complex, the Kd for peptide-Va interaction was calculated to be approximately 10 microM as compared with 30 pM for factor Xa and approximately 1.5 microM for decarboxylated factor Xa. A peptide containing residues 238-262(58-82) bound Ca2+ with reduced affinity (Kd approximately 600 microM) and did not inhibit Xa:Va interaction. In contrast, a peptide containing residues 253-277(73-97) inhibited Xa:Va interaction (Kd approximately 10 microM) but did not bind Ca2+. In additional studies, Ca2+ increased the amidolytic activity of native and des-44-Xa toward a tetrapeptide substrate (benzoyl-Ile-Glu-Gly-Arg-p-nitroanilide) by approximately 1.6-fold. The half-maximal increase was observed at approximately 150 microM Ca2+ and the effect was primarily on the kcat. Ca2+ also significantly protected cleavage at Arg-332-Gln-333(150-151) in the protease domain autolysis loop. Des-44-Xa in which the autolysis loop was cleaved possessed </=5% of the amidolytic activity of the noncleaved form; however, the S1 binding site was not affected, as determined by the p-aminobenzamidine binding. Additionally, autolysis loop-cleaved, active site-blocked native factor Xa was calculated to have approximately 10-fold reduced affinity for factor Va as compared with that of the noncleaved form.
人凝血因子X是一种双链、58 kDa的维生素K依赖性血液凝固酶原。因子X的轻链由一个NH2末端的γ-羧基谷氨酸(Gla)结构域组成,其后是一些螺旋状疏水残基和两个表皮生长因子样结构域,而重链则包含丝氨酸蛋白酶结构域。在本研究中,发现天然因子X含有三类Ca2+结合位点:两个高亲和力位点(Kd 100±30 μM)、四个中等亲和力位点(Kd 450±70 μM)以及五到六个低亲和力位点(Kd 2±0.2 mM)。Gla残基转化为Glu的脱羧因子X保留了两个高亲和力位点(Kd 140±20 μM)。相比之下,缺乏Gla结构域以及部分螺旋状疏水残基的因子X(des-44-X)仅保留了一个高亲和力Ca2+结合位点(Kd 130±20 μM)。此外,由因子X蛋白酶结构域的238-277位残基(按照胰凝乳蛋白酶原编号为58-97)组成的合成肽以高亲和力结合一个Ca2+(Kd 150±20 μM)。从活性位点被阻断的因子Xa与凝血酶原酶复合物中因子Va结合的竞争性抑制试验可知,肽与Va相互作用的Kd计算约为10 μM,而因子Xa的Kd为30 pM,脱羧因子Xa的Kd约为1.5 μM。含有238-262位残基(58-82)的肽以降低的亲和力结合Ca2+(Kd约600 μM),并且不抑制Xa:Va相互作用。相反,含有253-277位残基(73-97)的肽抑制Xa:Va相互作用(Kd约10 μM),但不结合Ca2+。在其他研究中,Ca2+使天然和des-44-Xa对四肽底物(苯甲酰-Ile-Glu-Gly-Arg-对硝基苯胺)的酰胺水解活性增加约1.6倍。在约150 μM Ca2+时观察到最大增加量的一半,且该效应主要作用于kcat。Ca2+还显著保护蛋白酶结构域自溶环中Arg-332-Gln-333(150-151)处的切割。自溶环被切割的des-44-Xa具有未切割形式酰胺水解活性的≤5%;然而,通过对氨基苯甲脒结合测定,S1结合位点未受影响。此外,与未切割形式相比,自溶环被切割、活性位点被阻断的天然因子Xa对因子Va的亲和力计算降低了约10倍。